Gene-Edited Pig Kidney Reaches 9-Month Milestone in Human Patient
Researchers have achieved a significant milestone in the field of xenotransplantation, with a gene-edited pig kidney maintaining function in a human recipient for nine months—marking the longest recorded success for this experimental approach.
The transplanted kidney, derived from a pig that underwent genetic modifications, has continued filtering blood and producing urine without signs of rejection, according to preliminary reports from the research team. This achievement builds on earlier, shorter-duration pig kidney transplants that also showed promise.
The ongoing success addresses one of the primary challenges in xenotransplantation: preventing the human immune system from attacking foreign animal tissue. By editing specific genes in donor pigs, researchers have been able to reduce the risk of immediate rejection and complications that plagued earlier attempts.
For the approximately 90,000 Americans currently on the kidney transplant waiting list, this development offers a potential pathway to a life-saving alternative when human donors are unavailable. While significant regulatory and ethical hurdles remain before such procedures could become routine, the nine-month milestone represents meaningful progress toward making xenotransplantation a viable clinical option.
The research team has indicated plans to continue monitoring the patient while working toward larger clinical trials to further evaluate the safety and long-term effectiveness of gene-edited pig kidneys.